Willis Towers Watson to acquire TRANZACT - Clayton, Dubilier
https://www.cdr-inc.com/news/press-release/willis-towers-watson-acquire-tranzact
WebWillis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, announced today the acquisition of TRANZACT, a direct-to-consumer health care organization that links individuals to U.S. insurance carriers. TRANZACT was acquired by its current majority owner, a Clayton, Dubilier & Rice (CD&R) fund, in 2016.
DA: 54 PA: 50 MOZ Rank: 89